Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers alleviate symptoms of Rett syndrome in mice

02.02.2006


Rett syndrome is a debilitating neurological disorder occurring primarily in girls. While some existing therapies might ease particular symptoms of the condition, there is no current way to address the syndrome at a molecular level. Now, researchers at Whitehead Institute for Biomedical Research, in collaboration with scientists at Brandeis University, have dramatically reduced certain manifestations of Rett Syndrome in mice, marking a clear path in which to explore possible therapies for people.



"This is the first time we’ve successfully reduced the awful symptoms of Rett syndrome using transgenic techniques," says Whitehead Member Rudolf Jaenisch, senior author of the paper that will be published February 2 in the journal Neuron. "Once we understand the molecular mechanisms of the disease we may be able to design rational strategies that may eventually be useful for the improving the condition in people."

Rett syndrome, whose incidence is roughly 1 in 15,000, is caused by a defective gene on the X chromosome. Most boys with Rett syndrome die before birth. Girls with Rett develop normally until about six to eighteen months, when things begin to go terribly wrong. Their health deteriorates, and they begin to show symptoms such as loss of speech, loss of voluntary motor control, constant hand wringing and seizures.


In March 2001, researchers in the Jaenisch lab published a paper in Nature Genetics describing how they had created the first mouse with Rett syndrome by disabling a gene called MeCP2. Normally, MeCP2 regulates the activities of other genes, particularly those in the brain. When it is shut off completely, the mice become lethargic and a major class of cortical neurons became far less active--classic symptoms of Rett.

In the fall of 2003, Jaenisch and researchers at Children’s Hospital Boston reported in the journal Science that MeCP2 interacted with a neuronal gene called Bdnf, a gene that’s highly active in infants age 6 to 18 months--the same age at which Rett symptoms first appear. But since this study was conducted using explanted neurons in a laboratory dish, researchers still had many unanswered questions about the role of Bdnf in Rett disease progression in mice.

Qiang Chang, a postdoctoral scientist in the Jaenisch lab, began to explore this issue by studying the population of the MeCP2 knock-out mice that Jaenisch had reported on in 2001. His first finding, gleaned through analyzing brain tissue, was not altogether unexpected: Mice without MeCP2 also showed low expression levels of the BDNF protein. In fact, Chang discovered that when he knocked out Bdnf altogether in normal mice, symptoms similar to those observed in the Rett mice occurred. But to discover whether or not these finding might have therapeutic relevance, Chang needed to engage in some complex genetic tinkering.

Chang inserted an additional Bdnf gene into the early embryos of the MeCP2 knock-out mice. He designed the gene so that it would be free of all normal regulatory mechanisms, in effect ensuring that it remains in a state of constant activity. In other words, while MeCP2 was permanently shut off, the new Bdnf was permanently switched on, and at maximum capacity.

This time, the findings were striking.

With BDNF hyper-expressed, Chang witnessed a drastic reduction in certain Rett symptoms. The mice were far less lethargic, and activity in the cortical neurons increased. These mice also had slightly larger brains, a longer lifespan and later onset of disease than the other Rett mice.

"The next step," says Chang, "is to figure out exactly why this is happening. Exactly how much BDNF expression in the mouse brain do you need to achieve these results, and where does it occur?"

"Knowing more about the process and about the precise areas of the brain that are affected will give us options for exploring future therapies," explains Jaenisch, who is also a professor of biology at MIT.

"We’re encouraged by these results," says Monica Coenraads, co-founder and director of research for Rett Syndrome Research Foundation, who helped support this work. "Should this prove to be therapeutically relevant, we look forward to participating in the transition from lab to clinic."

David Cameron | EurekAlert!
Further information:
http://www.wi.mit.edu

More articles from Life Sciences:

nachricht Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>